This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: acute myocardial infarction

Acute coronary syndrome in adults: scope of the problem in the UK

September 2017 Br J Cardiol 2017;24(suppl 1):S3–S9 doi:10.5837/bjc.2017.s01

Acute coronary syndrome in adults: scope of the problem in the UK

Chris P Gale

Abstract

Definition of ACS Acute coronary syndromes (ACS) include unstable angina and acute myocardial infarction (AMI). AMI is classified according to those patients with electrocardiographic ST-segment elevation, ST-elevation myocardial infarction (STEMI) and those without electrocardiographic ST-segment elevation, non-ST-elevation myocardial infarction (NSTEMI).1 The requirement for a diagnosis of AMI in the universal definition is the detection of troponin release from injured cardiac myocytes with at least one value >99th centile of the upper reference limit.1 Diagnosis is confirmed only if this is associated with at least one of: symptoms of

| Full text

October 2015 Br J Cardiol 2015;22:138–142 Online First

News from the European Society of Cardiology Congress 2015

BJCardio Staff

Abstract

(more…)

| Full text
Primary angioplasty for acute STEMI in secondary care: feasibility, outcomes and potential advantages

March 2013 Br J Cardiol 2013;20:32–7 doi:10.5837/bjc.2013.007

Primary angioplasty for acute STEMI in secondary care: feasibility, outcomes and potential advantages

Andrew Whittaker, Lee Rowell, Olayiwola Olatawura, Petra Poliacikova, Jason Glover, Carl I Brookes, Andrew J Bishop

Abstract

Introduction On inference from a range of randomised clinical trials, timely primary percutaneous coronary intervention (PPCI) has become the optimal strategy for the treatment of ST-segment elevation myocardial infarction (STEMI).1-8 Despite the logistic complexity and potential for delay compared with fibrinolytic treatment, the standard outcomes of safety and effectiveness of PPCI are superior to fibrinolysis unless the time delay is substantial.9-12 These data have led to the decision that, not only should PPCI be the treatment of choice for STEMI in England, it must be available 24 hours per day, seven days per week.13 This generates log

| Full text
‘Time is muscle’: aspirin taken during acute coronary thrombosis

July 2010 Br J Cardiol 2010;17:185-9

‘Time is muscle’: aspirin taken during acute coronary thrombosis

Peter C Elwood, Gareth Morgan, Malcolm Woollard, Andrew D Beswick 

Abstract

Introduction Aspirin, used in vascular disease prophylaxis, is probably the most cost-effective drug available in clinical practice and daily low-dose aspirin is now a standard item in the long-term management of vascular disease. Within a public health context, the provision of aspirin to individuals at increased vascular risk has been judged to be the preventive activity of greatest benefit and at the lowest cost (by far), apart from smoking cessation.1 Patients with known vascular disease are clearly at increased vascular risk, and a recent US Task Force judged that ‘individuals at increased risk’ includes males aged over about 45 and

| Full text

July 2005 Br J Cardiol (Acute Interv Cardiol) 2005;12:AIC 56–AIC 59

Introduction of primary percutaneous coronary intervention for ST elevation myocardial infarction in a district general hospital

Sohail Qaisar, Melanie Fellows, Hannah Whitlam, Rumi Jaumdally, James M Beattie, Patricia J Lowry, Nadia El-Gaylani, Robert G Murray, Jerome Ment, Michael Pitt

Abstract

No content available

| Full text

May 2005 Br J Cardiol 2005;12:205-8

Heart failure after myocardial infarction: a neglected problem?

Martin R Cowie, Larry Lacey, Maggie Tabberer

Abstract

No content available

| Full text

July 2004 Br J Cardiol (Acute Interv Cardiol) 2004;11:AIC 68–AIC 69

Isolated ventricular non-compaction presenting as acute myocardial infarction

Divaka Perera, Dudley J Pennell, Barry J Kneale

Abstract

No content available

| Full text

January 2004 Br J Cardiol 2004;11:39-41

Redefining acute MI: the potential impact on rehabilitation services

Mark Snowden

Abstract

No content available

| Full text

May 2003 Br J Cardiol 2003;10:212-3

Use of nicotine replacement therapy early in recovery post-acute myocardial infarction to aid smoking cessation

Katherine A Willmer, Valerie Bell

Abstract

No content available

| Full text

November 2002 Br J Cardiol 2002;9:624-7

Early thrombolysis for the treatment of acute myocardial infarction. Who will provide this treatment in the UK? Part II.

Terry McCormack

Abstract

No content available

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now